ART Advanced Research Technologies Secures Two Orders For Its Optix MX2 Molecular Imaging System
Montreal, Quebec - ART Advanced Research Technologies Inc. ("ART"), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that it has received two orders for the recently released preclinical optical molecular imager, Optix MX2. The units are expected to be shipped before the end of the year. This represents the first Optix units sold by ART under its new commercial strategy.
"These orders of the Optix MX2 system demonstrate that we are on track to achieve revenue growth with our new commercialization strategy under the leadership of Dino DiCamillo, our new global sales and marketing executive for preclinical imaging," said Sebastien Gignac, President and CEO of ART.
"ART is building sales momentum with the new team in place and leveraging internal expertise in optical imaging to offer multiple solutions to Optix users. In addition to world class products, our intention is to provide world class service and application assistance to enable Optix users to fully utilize the potential of the newly released Optix MX2 and the innovative software solutions associated to the product in their research programs," concluded Dino DiCamillo, ART's Vice President, Global Sales & Marketing for Preclinical Imaging.
About the Optix system
Based on time-domain technology, which allows measurement of the light's time of arrival, the Optix in vivo optical molecular imaging device is the most sensitive optical imager commercially available on the precinical market, allowing for detection of lower concentrations of signals deeper inside the body. Unique to the Optix system is the ability to recover fluorescence lifetime, which can be used to separate and quantify probe distributions depending on their respective biochemical environment. Also part of the Optix product offering is a new CT fusion software package allowing researchers to export the scan obtained using Optix in DICOM format, and fuse it with Micro CT for a full 3D anatomical reference.
SOURCE: ART Advanced Research Technologies Inc.